United Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation, today announced the opening of its third Designated Pathogen-Free ( DPF) facility, The Dr. Bartley P. Griffith and Dr.
United Therapeutics moved quickly over the last week to reach a settlement agreement with Liquidia Technologies, Inc. that enables continuity of therapy for all patients with pulmonary arterial ...
A pre-specified subgroup analysis from the phase 3 ADVANCE OUTCOMES study showed that ralinepag reduced the risk of clinical worsening in patients with pulmonary arterial hypertension (PAH), ...
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the United States District Court ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results